GSK-239512
GSK-239512 is a novel histamine H(3) receptor antagonist. GSK-239512 was developed for the treatment of cognitive dysfunction in neurodegenerative disorders with mild to moderate Alzheimer's disease.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1544 |
| CAS # | 720691-69-0 |
| Pricing | Customizable size, Inquiry |
| Synonym | GSK-239512; GSK239512; GSK 239512; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C23H27N3O2 |
| Exact Mass | 377.21033 |
| Molecular Weight | 377.48 |
| Elemental Analysis | C, 73.18; H, 7.21; N, 11.13; O, 8.48 |
| IUPAC/Chemical Name | 2-Pyrrolidinone, 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)- |
| InChi Key | YFRBKEVUUCQYOW-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2 |
| SMILES Code | O=C1CCCN1c2ccc(Oc3ccc4CCN(CCc4c3)C5CCC5)nc2 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |